Showing results (271-280 of 330) with videos related to

Sort By:
Pageof 33
Nuklearmedizin. Nuclear Medicine|October 1, 1996
[Relationship between properties of 131I therapy and radioiodine kinetics]K Schomäcker, U Wellner, K Scheidhauer, et al.
Nuclear Medicine Communications|April 1, 1996
Immunoscintigraphy for the detection of brain abscessesD Sandrock, R Verheggen, A T Helwig, et al.
European Heart Journal|July 20, 2000
Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery diseaseF M Baer, P Theissen, J Crnac, et al.
Nuclear Medicine Communications|March 27, 1999
Positron emission tomography using 18F-fluorodeoxyglucose in advanced stages of malignant melanoma: a comparison of ultrasonographic and radiological methods of diagnosisM Dietlein, B Krug, W Groth, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|October 4, 2000
Fluor-18-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant melanoma. Diagnostic comparison with conventional imaging methodsB Krug, M Dietlein, W Groth, et al.
Nuklearmedizin. Nuclear Medicine|December 22, 1999
[Synthesis of tumor affinity label Yb-169- and Y-90- porphyrin complexes and animal experimental investigations with various Yb-169-porphyrins]K Schomäcker, M I Gaidouk, V D Rumyantseva, et al.
Journal of the American College of Cardiology|September 19, 1998
Significance of rest technetium-99m sestamibi imaging for the prediction of improvement of left ventricular dysfunction after Q wave myocardial infarction: importance of infarct location adjusted thresholdsC A Schneider, E Voth, S Gawlich, et al.
Nuklearmedizin. Nuclear Medicine|August 19, 2004
[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 2)]M Dietlein, J Dressler, J Farahati, et al.
Nuklearmedizin. Nuclear Medicine|December 9, 2004
[Guideline for radioiodine therapy for benign thyroid diseases (version 3)]M Dietlein, J Dressler, F Grünwald, et al.
Nuklearmedizin. Nuclear Medicine|September 12, 2006
Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004M Schmidt, T Simon, B Hero, et al.
Pageof 33